These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 22185672)
21. Surveillance of the efficacy of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum among children under five in Togo, 2005-2009. Dorkenoo MA; Barrette A; Agbo YM; Bogreau H; Kutoati S; Sodahlon YK; Morgah K Malar J; 2012 Oct; 11():338. PubMed ID: 23043495 [TBL] [Abstract][Full Text] [Related]
22. Comparative efficacies of artemisinin combination therapies in Plasmodium falciparum malaria and polymorphism of pfATPase6, pfcrt, pfdhfr, and pfdhps genes in tea gardens of Jalpaiguri District, India. Saha P; Guha SK; Das S; Mullick S; Ganguly S; Biswas A; Bera DK; Chattopadhyay G; Das M; Kundu PK; Ray K; Maji AK Antimicrob Agents Chemother; 2012 May; 56(5):2511-7. PubMed ID: 22314538 [TBL] [Abstract][Full Text] [Related]
23. Similar efficacy and safety of artemether-lumefantrine (Coartem®) in African infants and children with uncomplicated falciparum malaria across different body weight ranges. Bassat Q; González R; Machevo S; Nahum A; Lyimo J; Maiga H; Mårtensson A; Bashraheil M; Ouma P; Ubben D; Walter V; Nwaiwu O; Kipkeu C; Lefèvre G; Ogutu B; Menéndez C Malar J; 2011 Dec; 10():369. PubMed ID: 22176931 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of artemether-lumefantrine efficacy in the treatment of uncomplicated malaria and its association with pfmdr1, pfatpase6 and K13-propeller polymorphisms in Luanda, Angola. Kiaco K; Teixeira J; Machado M; do Rosário V; Lopes D Malar J; 2015 Dec; 14():504. PubMed ID: 26670642 [TBL] [Abstract][Full Text] [Related]
25. Comparison of artesunate-mefloquine and artemether-lumefantrine fixed-dose combinations for treatment of uncomplicated Plasmodium falciparum malaria in children younger than 5 years in sub-Saharan Africa: a randomised, multicentre, phase 4 trial. Sirima SB; Ogutu B; Lusingu JPA; Mtoro A; Mrango Z; Ouedraogo A; Yaro JB; Onyango KO; Gesase S; Mnkande E; Ngocho JS; Ackermann I; Aubin F; Vanraes J; Strub N; Carn G Lancet Infect Dis; 2016 Oct; 16(10):1123-1133. PubMed ID: 27430374 [TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria at sentinel sites in Mozambique, 2015. Salvador C; Rafael B; Matsinhe F; Candrinho B; Muthemba R; De Carvalho E; Naueia E; Sacarlal J; Namboze J; Tiago A; Warsame M; Enosse S Acta Trop; 2017 Jul; 171():146-150. PubMed ID: 28373036 [TBL] [Abstract][Full Text] [Related]
27. Efficacy of fixed-dose combination artesunate-amodiaquine versus artemether-lumefantrine for uncomplicated childhood Plasmodium falciparum malaria in Democratic Republic of Congo: a randomized non-inferiority trial. Espié E; Lima A; Atua B; Dhorda M; Flévaud L; Sompwe EM; Palma Urrutia PP; Guerin PJ Malar J; 2012 May; 11():174. PubMed ID: 22631564 [TBL] [Abstract][Full Text] [Related]
28. Artesunate-amodiaquine versus artemether-lumefantrine for the treatment of acute uncomplicated malaria in Congolese children under 10 years old living in a suburban area: a randomized study. Ndounga M; Pembe Issamou Mayengue ; Casimiro PN; Koukouikila-Koussounda F; Bitemo M; Diassivy Matondo B; Ndounga Diakou LA; Basco LK; Ntoumi F Malar J; 2015 Oct; 14():423. PubMed ID: 26511848 [TBL] [Abstract][Full Text] [Related]
29. Usefulness of Plasmodium falciparum-specific rapid diagnostic tests for assessment of parasite clearance and detection of recurrent infections after artemisinin-based combination therapy. Aydin-Schmidt B; Mubi M; Morris U; Petzold M; Ngasala BE; Premji Z; Björkman A; Mårtensson A Malar J; 2013 Oct; 12():349. PubMed ID: 24079306 [TBL] [Abstract][Full Text] [Related]
30. Therapeutic efficacy and effect on gametocyte carriage of an artemisinin and a non-based combination treatment in children with uncomplicated P. falciparum malaria, living in an area with high-level chloroquine resistance. Okafor HU; Shu EN; Oguonu T J Trop Pediatr; 2010 Dec; 56(6):398-406. PubMed ID: 20144932 [TBL] [Abstract][Full Text] [Related]
31. The effect of dose on the antimalarial efficacy of artemether-lumefantrine: a systematic review and pooled analysis of individual patient data. Worldwide Antimalarial Resistance Network (WWARN) AL Dose Impact Study Group Lancet Infect Dis; 2015 Jun; 15(6):692-702. PubMed ID: 25788162 [TBL] [Abstract][Full Text] [Related]
32. A comparative study on the efficacy of artesunate plus sulphadoxine/pyrimethamine versus artemether-lumefantrine in eastern Sudan. Mukhtar EA; Gadalla NB; El-Zaki SE; Mukhtar I; Mansour FA; Babiker A; El-Sayed BB Malar J; 2007 Jul; 6():92. PubMed ID: 17631681 [TBL] [Abstract][Full Text] [Related]
33. Similar efficacy and tolerability of double-dose chloroquine and artemether-lumefantrine for treatment of Plasmodium falciparum infection in Guinea-Bissau: a randomized trial. Ursing J; Kofoed PE; Rodrigues A; Blessborn D; Thoft-Nielsen R; Björkman A; Rombo L J Infect Dis; 2011 Jan; 203(1):109-16. PubMed ID: 21148503 [TBL] [Abstract][Full Text] [Related]
34. Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria in Papua New Guinea. Tavul L; Hetzel MW; Teliki A; Walsh D; Kiniboro B; Rare L; Pulford J; Siba PM; Karl S; Makita L; Robinson L; Kattenberg JH; Laman M; Oswyn G; Mueller I Malar J; 2018 Oct; 17(1):350. PubMed ID: 30290825 [TBL] [Abstract][Full Text] [Related]
35. Plasmodium falciparum msp1 and msp2 genetic diversity and allele frequencies in parasites isolated from symptomatic malaria patients in Bobo-Dioulasso, Burkina Faso. Somé AF; Bazié T; Zongo I; Yerbanga RS; Nikiéma F; Neya C; Taho LK; Ouédraogo JB Parasit Vectors; 2018 May; 11(1):323. PubMed ID: 29843783 [TBL] [Abstract][Full Text] [Related]
36. Prevalence of single nucleotide polymorphisms in the Plasmodium falciparum multidrug resistance gene (Pfmdr-1) in Korogwe District in Tanzania before and after introduction of artemisinin-based combination therapy. Thomsen TT; Ishengoma DS; Mmbando BP; Lusingu JP; Vestergaard LS; Theander TG; Lemnge MM; Bygbjerg IC; Alifrangis M Am J Trop Med Hyg; 2011 Dec; 85(6):979-83. PubMed ID: 22144430 [TBL] [Abstract][Full Text] [Related]
37. Genetic diversity of Singana BP; Mayengue PI; Niama RF; Ndounga M Pan Afr Med J; 2019; 32():183. PubMed ID: 31312296 [TBL] [Abstract][Full Text] [Related]
38. Amodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up. Adjei GO; Kurtzhals JA; Rodrigues OP; Alifrangis M; Hoegberg LC; Kitcher ED; Badoe EV; Lamptey R; Goka BQ Malar J; 2008 Jul; 7():127. PubMed ID: 18620577 [TBL] [Abstract][Full Text] [Related]
39. Assessment of the therapeutic efficacy of a paediatric formulation of artemether-lumefantrine (Coartesiane) for the treatment of uncomplicated Plasmodium falciparum in children in Zambia. Chanda P; Hawela M; Kango M; Sipilanyambe N Malar J; 2006 Aug; 5():75. PubMed ID: 16938133 [TBL] [Abstract][Full Text] [Related]
40. Pyronaridine-artesunate granules versus artemether-lumefantrine crushed tablets in children with Plasmodium falciparum malaria: a randomized controlled trial. Kayentao K; Doumbo OK; Pénali LK; Offianan AT; Bhatt KM; Kimani J; Tshefu AK; Kokolomami JH; Ramharter M; de Salazar PM; Tiono AB; Ouédraogo A; Bustos MD; Quicho F; Borghini-Fuhrer I; Duparc S; Shin CS; Fleckenstein L Malar J; 2012 Oct; 11():364. PubMed ID: 23113947 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]